2019
DOI: 10.5144/0256-4947.2019.354
|View full text |Cite
|
Sign up to set email alerts
|

Superfluous amylase/lipase testing at a tertiary care hospital: a retrospective study

Abstract: BACKGROUND: Measuring both serum amylase and lipase in the setting of acute pancreatitis is not recommended and monitoring changes in amylase and lipase levels after diagnostic results is of little added value. The extent of the two types of superfluous amylase/lipase testing at our institution is unknown.OBJECTIVE: Explore the extent of superfluous amylase/lipase testing.DESIGN: Medical record review.SETTINGS: Tertiary care, teaching hospital.PATIENTS AND METHODS: We retrospectively reviewed all amylase and l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

4
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 14 publications
4
1
0
Order By: Relevance
“…Although studies have failed to demonstrate the prognostic value of repeat lipase measurement after the initial diagnosis of AP, 26 they are often obtained multiple times throughout the course of a single AP episode. 15,27 Consistent with prior studies, 15,27 our study showed that more than one-third of inpatients with AP had repeat lipase measurements after an initial lipase value that was diagnostic for AP. There is one clinical scenario in which serial lipase measurement may be warranted: if the initial presentation is within 4 to 5 hours of abdominal pain onset and lipase level is normal, but suspicion for AP is high.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Although studies have failed to demonstrate the prognostic value of repeat lipase measurement after the initial diagnosis of AP, 26 they are often obtained multiple times throughout the course of a single AP episode. 15,27 Consistent with prior studies, 15,27 our study showed that more than one-third of inpatients with AP had repeat lipase measurements after an initial lipase value that was diagnostic for AP. There is one clinical scenario in which serial lipase measurement may be warranted: if the initial presentation is within 4 to 5 hours of abdominal pain onset and lipase level is normal, but suspicion for AP is high.…”
Section: Discussionsupporting
confidence: 88%
“…Although studies have failed to demonstrate the prognostic value of repeat lipase measurement after the initial diagnosis of AP, 26 they are often obtained multiple times throughout the course of a single AP episode 15,27 . Consistent with prior studies, 15,27 our study showed that more than one-third of inpatients with AP had repeat lipase measurements after an initial lipase value that was diagnostic for AP.…”
Section: Discussionsupporting
confidence: 85%
“…Consequently, only 3.6% of the tests were diagnostic for acute pancreatitis [21]. Tis is in accordance with many investigations that have found that simultaneous requests for both serum amylase and lipase are unnecessary, since serum lipase alone has displayed better sensitivity and specifcity compared to serum amylase [7,8,[18][19][20][21][22]. Serum lipase has been demonstrated to have a higher diagnostic sensitivity than serum amylase [23].…”
Section: Discussionsupporting
confidence: 72%
“…In our study, 7.8% of serum amylase tests were repeated, and 3.3% were requested for serum amylase alone, which was lower than the rate of 12.4% reported in other studies. Consequently, only 3.6% of the tests were diagnostic for acute pancreatitis [ 21 ]. This is in accordance with many investigations that have found that simultaneous requests for both serum amylase and lipase are unnecessary, since serum lipase alone has displayed better sensitivity and specificity compared to serum amylase [ 7 , 8 , 18 – 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Our findings indicate that the combination of serum amylase and lipase is not a superior testing modality than serum lipase alone. Although our study did not evaluate symptomatology, we support the recommendations of using serum lipase in specific instances, 5,10,15,21 thus decreasing serum amylase use by at least 85% without compromising patient care. 1,22 This will lead to financial savings, minimal loss of clinically useful information, and a reduction in health care waste and resources.…”
Section: Discussionsupporting
confidence: 69%